Results 161 to 170 of about 1,729 (249)

Defect phases beyond grain boundaries. [PDF]

open access: yesMRS Bull
Korte-Kerzel S   +4 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Diarylethene‐Containing Photoswitchable Analogues of Tubulysins—Design, Synthesis, Biological, and Structural Evaluation

open access: yesEuropean Journal of Organic Chemistry, EarlyView.
Diarylethene‐containing cyclic tubulysin analogues were designed, synthesized, and evaluated as light‐responsive cytotoxic agents. One analogue showed reversible photoswitching, photoregulated tubulin polymerization inhibition, and photoform‐dependent cytotoxicity.
Anna Iampolska   +9 more
wiley   +1 more source

M2 Macrophage‐Mimetic and ROS‐Sensitive Hybrid Nanoplatform for Targeted Alleviation of Rheumatoid Arthritis

open access: yesExploration, EarlyView.
Rheumatoid arthritis (RA) is the most prevalent inflammatory arthropathy globally and remains incurable nowadays. Herein, an M2 macrophage‐mimetic hybrid nanoplatform (Cel@M2‐L‐MSN) is constructed for concerted RA therapy through joint‐specific accumulation, on‐demand drug release, inflammation resolution, ROS clearance, along with macrophage ...
Yi Xiao   +11 more
wiley   +1 more source

An Ocular Surface‐Targeting Nucleic Acid Hydrogel for Efficient Dry Eye Disease Treatment

open access: yesExploration, EarlyView.
A self‐assembled nucleic acid hydrogel modified with mucin‐1 (MUC1) aptamer is developed, which can actively target the mucin layer on the ocular surface and significantly extend its retention time after distillation. Inside the hydrogel, therapeutic siRNA is embedded and can effectively silence the inflammation gene expression, subsequently restoring ...
Yuhe Liu   +12 more
wiley   +1 more source

Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology

open access: yesExploration, EarlyView.
Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy